510(k) K933722
K933722 is an FDA 510(k) premarket notification submitted by Horizon Diagnostics, Inc. for the device "HORIZON DIAGNOSTICS TRIGLYCERIDES-GPO REAGENT". The FDA issued a decision of Substantially Equivalent on June 13, 1996. The device falls under product code CDT (Lipase Hydrolysis/Glycerol Kinase Enzyme, Triglycerides), a Class I device regulated under 21 CFR 862.1705. Horizon Diagnostics, Inc. has at least 6 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- June 13, 1996
- Date Received
- August 2, 1993
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Lipase Hydrolysis/Glycerol Kinase Enzyme, Triglycerides
- Device Class
- Class I
- Regulation Number
- 862.1705
- Review Panel
- CH
- Submission Type